Jeff Cislini, General Counsel at Revolution Medicines, Inc. (RVMD), sold 2,916 shares at $39.04 ($114K) on 2025-03-17, disclosed to the SEC on 2025-03-19.
Scheduled sale ($114k) by General Counsel under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $39.04 | 1,458 | $57K | 50.0% |
| 2 | $39.04 | 1,458 | $57K | 50.0% |
| Total | $39.04 avg | 2,916 | $114K | 100% |
| Filing → |
| RVMD | SELL | 2026-08-25 | $11.9M | — | Filing → |
| RVMD | SELL | 2026-06-18 | $337K | — | Filing → |
| RVMD | SELL | 2026-03-19 | $470K | — | Filing → |